Monitoring metabolic responses after induction of hypoxia in the KHT tumour using 31P NMR spectroscopy.
Bremner
J C
JC
MRC Radiobiology Unit, Chilton, Didcot, UK.
Counsell
C J
CJ
Edwards
H S
HS
Stratford
I J
IJ
Adams
G E
GE
Nethersell
A B
AB
Bedford
P
P
D000818:Animals; D001547:Benzaldehydes / Q000494:pharmacology; D015687:Cell Hypoxia / Q000502:physiology*; D003250:Constriction; D006830:Hydralazine / Q000494:pharmacology; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D008809:Mice, Inbred C3H; D008920:Misonidazole / Q000031:analogs & derivatives / Q000494:pharmacology; D008991:Monitoring, Physiologic; D009368:Neoplasm Transplantation; D009943:Organophosphorus Compounds / Q000378:metabolism; D010710:Phosphates / Q000378:metabolism; D012513:Sarcoma, Experimental / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D001547:Benzaldehydes; D009943:Organophosphorus Compounds; D010710:Phosphates; D014409:Tumor Necrosis Factor-alpha; D006830:Hydralazine; C039599:5-(2-formyl-3-hydroxyphenoxy)pentanoic acid; C041712:1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol; D008920:Misonidazole